Application | Comment | Organism |
---|---|---|
medicine | inhibitors from Spiraea cantoniensis could be physiologically useful for treatment of diabetes | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
kaempferol 3-O-(6-O-caffeoyl)-beta-D-galactoside | flavonol caffeoylglycoside from Spiraea cantoniensis flower | Rattus norvegicus | |
kaempferol 3-O-(6-O-caffeoyl)-beta-D-glucoside | flavonol caffeoylglycoside from Spiraea cantoniensis flower | Rattus norvegicus | |
quercetin 3-O-(6-O-caffeoyl)-beta-D-galactoside | flavonol caffeoylglycoside from Spiraea cantoniensis flower | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
intestine | - |
Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
shows specific activity of 0.70 U/ml | Rattus norvegicus |
Synonyms | Comment | Organism |
---|---|---|
alpha-glucosidase | - |
Rattus norvegicus |
maltase | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.085 | - |
- |
Rattus norvegicus | quercetin 3-O-(6-O-caffeoyl)-beta-D-galactoside | |
0.35 | - |
- |
Rattus norvegicus | kaempferol 3-O-(6-O-caffeoyl)-beta-D-galactoside | |
0.47 | - |
- |
Rattus norvegicus | kaempferol 3-O-(6-O-caffeoyl)-beta-D-glucoside |